+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Metastatic Brain Tumor Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 272 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4767898
The global clinical trial report- “2019 Metastatic Brain Tumor Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Brain Tumor. It presents in-depth analysis of Metastatic Brain Tumor clinical trials across markets and companies. The research work is for providing complete understanding into trends in Metastatic Brain Tumor.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Metastatic Brain Tumor clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Metastatic Brain Tumor

The research work is prepared through extensive and continuous research on Metastatic Brain Tumor trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Metastatic Brain Tumor patients are identified

  • The report includes panorama of Metastatic Brain Tumor clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Metastatic Brain Tumor clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Metastatic Brain Tumor Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Metastatic Brain Tumor Clinical Trials by Region
2.2.2 Average Enrollment of Metastatic Brain Tumor Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Metastatic Brain Tumor Treatment, 2019
3. Region wise Metastatic Brain Tumor Clinical Trials
3.1 Asia Pacific Metastatic Brain Tumor Clinical Trials by Country
3.2 Europe Metastatic Brain Tumor Clinical Trials by Country
3.3 North America Metastatic Brain Tumor Clinical Trials by Country
3.4 Middle East and Africa Metastatic Brain Tumor Clinical Trials by Country
3.5 South and Central America Metastatic Brain Tumor Clinical Trials by Country
4. Metastatic Brain Tumor Clinical Trial Trends
4.1 Start Year wise Metastatic Brain Tumor Clinical Trials
4.2 Phase wise Metastatic Brain Tumor Clinical Trials
4.3 Trial Status wise Metastatic Brain Tumor Clinical Trials
4.4 Trial Type wise Metastatic Brain Tumor Clinical Trials
5. Metastatic Brain Tumor Average Enrollment Trends
5.1 Average Enrollment in Metastatic Brain Tumor Trials by Year
5.2 Average Enrollment in Metastatic Brain Tumor Trials by Phase
5.3 Average Enrollment in Metastatic Brain Tumor Trials by Status
5.4 Average Enrollment in Metastatic Brain Tumor Trials by Type of Trial
6. Companies Participating in Metastatic Brain Tumor Clinical Trials
6.1 Metastatic Brain Tumor Trials by Sponsor Type
6.2 Metastatic Brain Tumor Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Metastatic Brain Tumor Trials- Phase 1
7.2 Metastatic Brain Tumor Trials- Phase 2
7.3 Metastatic Brain Tumor Trials- Phase 3
7.4 Metastatic Brain Tumor Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Metastatic Brain Tumor Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Figure 5: Europe - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Figure 7: North America - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Figure 9: Metastatic Brain Tumor Clinical Trials by Phase
Figure 10: Metastatic Brain Tumor Clinical Trials by Trial Status
Figure 11: Metastatic Brain Tumor Clinical Trials by Type
Figure 12: Metastatic Brain Tumor Clinical Trials by Sponsor Type
Figure 13: Metastatic Brain Tumor Clinical Trials by Leading Sponsors
Figure 14: Metastatic Brain Tumor Average Enrollment by Phase
Figure 15: Metastatic Brain Tumor Average Enrollment by Trial Status
Figure 16: Metastatic Brain Tumor Average Enrollment by Type
Figure 17: Metastatic Brain Tumor- Average Enrolment by Type of Sponsors
Figure 18: Metastatic Brain Tumor- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Metastatic Brain Tumor Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Table 5: Europe - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Table 7: North America - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Metastatic Brain Tumor Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Metastatic Brain Tumor Average Enrollment by Phase
Table 15: Metastatic Brain Tumor Average Enrollment by Trial Status
Table 16: Metastatic Brain Tumor Average Enrollment by Type
Table 17: Metastatic Brain Tumor- Average Enrolment by Type of Sponsors
Table 18: Metastatic Brain Tumor- Enrolment by Leading Sponsors

Companies Mentioned

  • AbbVie Inc

  • AngioChem Inc

  • Bristol-Myers Squibb Co

  • F. Hoffmann-La Roche Ltd

  • GlaxoSmithKline Plc

  • Merck & Co Inc

  • Novartis AG

  • Pfizer Inc

  • Puma Biotechnology Inc

  • Sanofi